Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gemox Chemotherapy”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Large-scale testing (Phase 3)Ended earlyNCT02359162
What this trial is testing

Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage

Who this might be right for
Lymphoma, Extranodal NK-T-Cell
Sun Yat-sen University 50
Large-scale testing (Phase 3)Study completedNCT01313377
What this trial is testing

Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
UNICANCER 190
Testing effectiveness (Phase 2)UnknownNCT04506281
What this trial is testing

PD1 Antibody (Toripalimab), GEMOX and Lenvatinib Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Shanghai Zhongshan Hospital 128
Testing effectiveness (Phase 2)Looking for participantsNCT06925516
What this trial is testing

A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 38
Testing effectiveness (Phase 2)Looking for participantsNCT06313203
What this trial is testing

HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)

Who this might be right for
Intrahepatic CholangiocarcinomaChemotherapy Effect
Oslo University Hospital 39
Testing effectiveness (Phase 2)UnknownNCT04961788
What this trial is testing

Anti-PD1 Antibody Toripalimab Combined With Gemox as First-line Therapy in Late-stage Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00425841
What this trial is testing

Stereotactic Radiation Therapy and Combination Chemotherapy in Treating Patients Undergoing Surgery for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Technical University of Munich 29
Testing effectiveness (Phase 2)Ended earlyNCT02533323
What this trial is testing

P-Gemox Regimen as First-line Chemotherapy in NK/T Lymphoma Patiens

Who this might be right for
Lymphoma, Extranodal NK-T-Cell
Sun Yat-sen University 50
Large-scale testing (Phase 3)Ended earlyNCT00470340
What this trial is testing

Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients

Who this might be right for
Liver NeoplasmsLiver CirrhosisCarcinoma, Hepatocellular+2 more
Assistance Publique - Hôpitaux de Paris 263
Large-scale testing (Phase 3)Looking for participantsNCT06904170
What this trial is testing

Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
UNICANCER 196
Testing effectiveness (Phase 2)Study completedNCT03092895
What this trial is testing

SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC

Who this might be right for
Advanced Primary Liver CancerAdvanced Biliary Tract Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 157
Large-scale testing (Phase 3)Active Not RecruitingNCT04669496
What this trial is testing

Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

Who this might be right for
Intrahepatic CholangiocarcinomaPD1 AntibodyLenvatinib+1 more
Shanghai Zhongshan Hospital 178
Testing effectiveness (Phase 2)Study completedNCT07304388
What this trial is testing

HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Sun Yat-sen University 96
Not applicableLooking for participantsNCT06505486
What this trial is testing

GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 21
Large-scale testing (Phase 3)WithdrawnNCT02534337
What this trial is testing

Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University
Testing effectiveness (Phase 2)UnknownNCT06320301
What this trial is testing

Adebrelimab and a TKI in Combination With GEMOX in First-line Treatment of Advanced Biliary Tract Cancers (BTC)

Who this might be right for
Biliary Tract CancerGemox Chemotherapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 43
Testing effectiveness (Phase 2)UnknownNCT04523402
What this trial is testing

Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma With High Predict Risk of Lymph Node Metastasis

Who this might be right for
Intrahepatic Cholangiocarcinoma Recurrent
Eastern Hepatobiliary Surgery Hospital 100
Testing effectiveness (Phase 2)Study completedNCT01562977
What this trial is testing

Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCL

Who this might be right for
Aggressive LymphomaDiffuse Large B-cell LymphomaMantle Cell Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 82
Testing effectiveness (Phase 2)UnknownNCT03825328
What this trial is testing

A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC )

Who this might be right for
Pancreatic Cancer
Yanqiao Zhang 30
Testing effectiveness (Phase 2)Study completedNCT01505413
What this trial is testing

Phase 2 Study of Erlotinib, Gemcitabine and Oxaliplatin Combination Chemotherapy to Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Soonchunhyang University Hospital 33
Load More Results